{"task_id": "a5f28d94dcc16042", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 372/464)", "text": "\nFever and Rash (p. 234)\n364\nExanthematous Lesions\n\n--- Page 386 ---\nSPECIFIC ENTITIES\nPARVOVIRUS B19\nslapped cheek rash on face and\nerythematous eruption on trunk, neck, and extremi\nties. Also called fifth disease or erythema infectiosum.\nFever may be present. Parvovirus B19 is also associated\nwith aplastic anemia, polyarthritis, and fetal hydrops\nSTAPHYLOCOCCAL SCALDED SKIN SYNDROME (SSSS)\n\u0002\nPATHOPHYSIOLOGY\nexfoliatins by specific strains\nof staphylococci leading to desquamative disor\nder with cleavage at the granular layer of the\ndermis\n\u0002\nCLINICAL\nFEATURES\nfever, malaise, generalized\nmacular erythematous rash that evolves rapidly\ninto a scarlatiniform (sandpaper like) rash, fol\nlowed by an exfoliative phase with perioral exuda\ntion and crusting. Large radial fissures \"sunburst\"\naround the mouth and are one of the diagnostic\nfeatures. Nikolsky sign positive\n\u0002\nDIAGNOSIS\nculture from a site other than the blis\nters (blood, conjunctivae, nasopharynx) demon\nstrating staphylococci\n\u0002\nTREATMENTS\nantibiotics\nfor\ntreatment\nof\nstaphylococci\nTOXIC SHOCK SYNDROME\n\u0002\nPATHOPHYSIOLOGY\nexotoxin by specific strains of\nS. aureus or group A Streptococcus leading to clea\nvage at the granular layer of the dermis\nSPECIFIC ENTITIES (CONT\u2019D)\n\u0002\nCLINICAL\nFEATURES\nyoung person with fever,\nmalaise, generalized macular, erythematous rash\nincluding mucous membranes, palms and soles,\nevolves into petechiae, vesicles, and bullae. Ulcera\ntions may be seen on mucous membranes. Hypo\ntension and organ failure may occur\n\u0002\nTREATMENTS\nfluid resuscitation as needed, vanco\nmycin (30 mg/kg/day IV divided BID) or b lactam\nplus clindamycin (600 mg IV q8h). If unresponsive\nto fluids or vasopressors, consider IVIG (400 mg/kg\n\u00031 dose, limited evidence)\nSCARLET FEVER\n\u0002\nPATHOPHYSIOLOGY\nerythrogenic toxin by specific\nstrains of group A Streptococcus leading to clea\nvage at the granular layer of the dermis\n\u0002\nCLINICAL FEATURES\nchildren with fever, sore throat,\npetechiae, and punctate red macules on hard and\nsoft palate and uvula (Forchheimer spots), circumoral\npallor, strawberry tongue, erythematous patches\ninvolving ears and chest, extend to trunk and extre\nmities and accentuate in skin folds (Pastia lines).\nEvolves to sandpaper like appearance. Desquamation\nhappens 7 10 days after resolution of rash\n\u0002\nTREATMENTS\nantibiotics and fluid resuscitation as\nneeded\nStevens\u2013Johnson Syndrome/Toxic Epidermal Necrolysis\nDIFFERENTIAL DIAGNOSIS OF VESICLES/BULLOUS\nLESIONS\nINFLAMMATORY\nbullous pemphigoid*, pemphi\ngus vulgaris*, porphyria cutanea tarda*, lupus*,\ndermatitis herpetiformis, erythema multiforme,\ncontact dermatitis\nINFECTIONS\n\u0002\nBACTERIAL\nbullous impetigo*, Staphylococcal\nscalded skin syndrome, toxic shock syndrome\n\u0002\nVIRAL\nHSV, VZV, molluscum contagiosum, Cox\nsackie virus\nNEOPLASTIC\nparaneoplastic pemphigus\nIATROGENIC\nStevens Johnson syndrome*, toxic\nepidermal necrolysis*\n*bullous lesions may be seen with or without\nvesicles\nPATHOPHYSIOLOGY\nHYPERSENSITIVITY REACTION\nStevens Johnson\nsyndrome (SJS) and toxic epidermal necrolysis (TEN)\nlie on a spectrum of serious, life threatening illness\ncharacterized by extensive epidermal necrosis. By\ndefinition, SJS involves less than 10% of the body\nsurface area (BSA) and TEN involves greater than 30%\nof the BSA. Involvement of 10 30% BSA is an overlap\nPATHOPHYSIOLOGY (CONT\u2019D)\nbetween the two. Drugs are the most common\noffending agents, but Mycoplasma pneumoniae,\nviruses, various chemicals and immunizations have\nalso been associated with SJS/TEN\nCOMMONLY ASSOCIATED DRUGS w4A\u2019Sw\n\u0002 Allopurinol\n\u0002 Antibiotics\nsulfamethoxazole,\ncephalosporins,\npenicillins, quinolones, macrolides\n\u0002 Antiinflammatory drugs\nNSAIDs, salicylates\n\u0002 Anticonvulsants\ncarbamazepine,\nphenytoin,\nlamotrigine, phenobarbital\nCLINICAL FEATURES\nTYPICAL PRESENTATION\npatients usually develop\nsymptoms within 2 3 weeks after drug exposure,\nmore rapidly in previously exposed patients. The pro\ndrome involves a flu like syndrome with fever, malaise,\narthralgias, myalgias, and mucous membrane lesions.\nThis is followed by the development of irregular target\nlikelesionsoften withnecroticcentersthatcoalesceover\ntime. Flaccid blisters form that spread with pressure\n(Nikolsky sign) resulting in sheet like loss of epidermis\nand exposure of the underlying dermis. 90% of patients\nhave mucous membrane involvement and 60% have\nocular involvement\nStevens\u2013Johnson Syndrome/Toxic Epidermal Necrolysis\n365", "text_length": 4408, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 372/464)", "type": "chunk", "chunk_index": 371, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.762333", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.763098", "status": "complete"